Trump meets Xi in Beijing: Boeing, ASML, rare earths, and LNG stocks face binary outcomes as tariffs, export controls, and purchase commitments hang in the balance.

Key Highlights

  • Boeing could secure Chinese aircraft orders for the first time in nearly a decade, with approximately 500 planes reportedly under discussion.
  • Rare earth producers China Northern Rare Earth and Xiamen Tungsten have more than doubled over the past year, making them direct barometers of any Supply normalisation deal.
  • WuXi Biologics faces structural Tariff risk as biotech firms with U.S. Revenue exposure fall outside expected strategic Waiver categories.
  • ASML and Hua Hong Semiconductor sit on opposite sides of any export control relaxation, with sharply contrasting implications.
  • China's track record on large purchase commitments remains mixed, with the 2020 Phase One agreement serving as a cautionary precedent.

Setting the Stakes

President Donald Trump's arrival in Beijing for high-stakes meetings with Chinese leader Xi Jinping has refocused Capital Markets attention on a broad cluster of equities carrying significant bilateral exposure. The agenda spans tariffs, rare earth access, semiconductor export controls, Taiwan, artificial intelligence, and the ongoing Iran conflict.

Markets have remained acutely sensitive to U.S.-China trade policy for years. Investors are now watching for signals, however incremental, that bilateral relations may stabilise. The base expectation across Wall Street is not a sweeping reset but a broadly constructive outcome sufficient to preserve the fragile detente that has underpinned risk assets since late 2025.

Aerospace: Boeing in the Room

Few companies carry as much symbolic and commercial weight in U.S.-China trade diplomacy as Boeing (NYSE: BA). The aerospace manufacturer has historically functioned as both a flagship American exporter and a recurring bargaining chip in bilateral negotiations.

Boeing's chief executive was among the Business leaders invited to accompany Trump on the trip, a detail markets have noted carefully. A potential Chinese commitment to purchase approximately 500 Boeing aircraft is reportedly on the table, which would constitute the company's first major Chinese order in close to a decade. Any formal signal of renewed procurement would represent a meaningful shift after years of strained relations that disrupted delivery pipelines with Chinese carriers. Aerospace analysts have described Boeing as the summit's most visible potential commercial winner.

Rare Earths: The Binary Trade

China controls over 70% of global rare earth supply, making the sector one of the most direct negotiating levers available to Beijing. China Northern Rare Earth High-Tech and Xiamen Tungsten have both more than doubled over the past year, driven by supply restriction fears and Beijing's periodic export curbs.

The summit outcome creates a genuinely binary dynamic. A deal normalising rare earth flows would represent a headwind for producers that have rallied precisely on the expectation of continued Scarcity. Any breakdown in talks, or deliberate Withholding of concessions, would sustain upward pressure on these names.

On the opposite side of that equation, companies most positively affected by a rare earth supply normalisation would be those heavily dependent on rare earth inputs across defence, clean energy, and advanced Manufacturing. MP Materials (NYSE:MP), the largest rare earth producer in the United States, stands to benefit from improved raw material access and pricing stability. Similarly, automakers with significant EV production pipelines, including Ford Motor (NYSE:F), would benefit from more stable magnet and battery material supply chains that currently face disruption risk from Chinese export policy.

Since late October, U.S.-China policy has revolved around a fragile arrangement in which Beijing paused rare earth export restrictions while Washington deferred new curbs on Chinese access to American technology. That baseline is what markets are now attempting to preserve or extend.

Semiconductors: Two Sides of the Same Negotiation

Chip-related equities represent the most structurally complex plays on any summit outcome, with different names positioned on opposite sides of the same policy lever.

ASML Holdings (Nasdaq:ASML) is among the names flagged as a potential beneficiary if the two sides reach a compromise on semiconductor equipment export controls. A relaxation of restrictions could drive upward revisions in forward estimates for the Dutch lithography equipment maker. A comparable dynamic played out last October, when a prior Trump-Xi engagement was followed by a one-year moratorium on new semiconductor equipment export bans and improved rare earth supply, contributing to a sharp recovery in China's semiconductor market during the second half of 2025.

On the opposite side sits Hua Hong Semiconductor, where U.S. regulators have reportedly halted tool shipments ahead of the summit. Any relaxation permitting equipment for more advanced 14 nanometer and 7 nanometer chip production would directly affect Hua Hong's manufacturing capacity and competitive positioning.

Chinese domestic semiconductor equipment makers, including Advanced Micro-Fabrication Equipment, present a more nuanced picture. Any thaw could initially weigh on these names as investors reassess the urgency of Import substitution. However, institutional analysis suggests such weakness would likely be a buying opportunity, given Beijing's unchanged long-term objective of semiconductor self-sufficiency. Dependence on foreign technology is still viewed as a structural vulnerability in Chinese policy circles regardless of short-term diplomatic progress.

Agricultural and Energy Exports: Headline Risk

Fresh Chinese commitments to purchase American agricultural products, liquefied Natural Gas, and Crude Oil are widely anticipated as part of any broader agreement framework.

On the agricultural side, large-scale Chinese grain purchase commitments would benefit U.S. crop producers and exporters most directly. Archer-Daniels-Midland (NYSE:ADM) and Bunge Global (NYSE:BG), two of the largest agricultural Commodity processors and exporters in the United States, would be among the clearest beneficiaries of any renewed Chinese buying programme given their deep exposure to soybean and corn export flows. Corteva (NYSE:CTVA), a major U.S. seed and crop protection company, would benefit from improved Downstream Demand signals for American farm output.

On the energy side, a resumption of large-scale Chinese LNG procurement would be most directly positive for Cheniere Energy (NYSE:LNG), the largest U.S. liquefied natural gas exporter, which has historically supplied Chinese buyers and maintains significant long-term contract capacity. ExxonMobil (NYSE:XOM) and Chevron (NYSE:CVX) carry material exposure to any uptick in Chinese crude oil purchase commitments given the scale of their production and export operations.

A secondary energy dimension stems from the Iran conflict. Any agreement on jointly addressing the closure of the Strait of Hormuz could offer near-term relief to global energy markets, though institutional analysis characterises this as a low-probability outcome at present. A reopening of the strait would paradoxically compress energy prices in the near term, creating a more nuanced read-through for U.S. producers whose near-term revenue benefits from elevated crude pricing.

Investors are cautioned against pricing in full implementation of announced purchase figures. The 2020 Phase One trade agreement, which temporarily de-escalated the first Trump-era Trade War, ultimately fell well short of its targeted Chinese import commitments. Large headline purchase numbers have been characterised as the lowest-hanging fruit in the bilateral economic relationship, carrying limited structural weight without sustained enforcement mechanisms.

Biotech: Structurally Exposed

WuXi Biologics has emerged as a name carrying elevated summit risk on the downside. Unlike energy and technology hardware companies, which are broadly expected to receive strategic waivers from the highest tariff tiers, biotech firms with material U.S. revenue exposure fall outside that perimeter.

Higher tariff levels would be particularly challenging for companies in this category. For WuXi Biologics specifically, the absence of a visible path to tariff relief represents a structural overhang that a constructive summit tone alone is unlikely to resolve. The risk here is less about what the summit delivers and more about what it fails to address.

Electric Vehicles and Battery Supply Chains

Electric vehicle and battery-related equities are being monitored for indirect read-throughs from any broader improvement in bilateral industrial relations. Contemporary Amperex Technology has attracted institutional attention, with its existing licensing arrangement with Ford Motor (NYSE:F) being cited as a potential structural template for future U.S.-China industrial cooperation should relations stabilise.

Broader upside scenarios flagged by institutional research include greater U.S. acceptance of Chinese green-technology Investment and incremental opening of China's financial sector to American firms. Both remain subject to restrictions in strategically sensitive areas and are unlikely to advance materially within the timeframe of a single summit.

Broader China Exporters: Tariff Stability as a Floor

Even in the absence of major breakthroughs, a stable tariff environment would provide a degree of improved visibility for broader Chinese exporters. Current U.S. levies on Chinese goods sit at an effective rate of approximately 22%. An absence of further escalation reduces Tail risk and improves supply chain planning certainty, even as existing tariff levels continue to cap medium-term upside for the segment.

Signal Versus Structure

The market response to the Trump-Xi summit will be shaped less by the content of any agreements than by the tone they establish. Incremental progress on tariffs, purchase commitments, and export control frameworks could provide a constructive short-term backdrop across the sectors in focus.

Structural tensions over technology supremacy, Taiwan, and supply chain decoupling are unlikely to resolve within the span of a bilateral meeting. Investors with exposure to these sectors would be well-served to distinguish between diplomatic signalling and durable policy change, a distinction that has repeatedly proven consequential across prior rounds of U.S.-China negotiation.